汇宇制药:盐酸尼卡地平注射液获药品注册证书

Core Viewpoint - The company Huayu Pharmaceutical (688553) has received approval from the National Medical Products Administration for its product, Nicardipine Hydrochloride Injection, which is used for the emergency treatment of abnormal hypertension during surgery and hypertensive emergencies [1] Group 1 - The product Nicardipine Hydrochloride Injection has been granted a drug registration certificate [1] - The clinical application of the product focuses on managing high blood pressure in urgent medical situations [1]

Huiyu Pharmaceutical-汇宇制药:盐酸尼卡地平注射液获药品注册证书 - Reportify